Topic Highlight
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Mar 21, 2009; 15(11): 1289-1300
Published online Mar 21, 2009. doi: 10.3748/wjg.15.1289
Figure 5
Figure 5 HCC. A: T1-weighted fat-suppressed sequence following gadolinium intravenous injection shows arterial phase enhancement of a focal liver lesion in segment IV (arrow); B: HCC: The same lesion as shown in Figure 5A becomes relatively less conspicuous on the portal phase images (arrow) as the surrounding liver parenchyma begins to enhance.